尽管纤维支气管镜检查较为安全,但仔细地分析其死亡和危及生命的并发症还是必要的。在Suratt报道的病例中,有2名在检查过程中因支气管内肿瘤大量出血死亡,11例支气管内膜病变在活检或刷洗过程中发生了危及生命的出血。还有10例死于心脏骤停。5例记录年龄的死者都超过67岁。这些病例大都有冠状动脉疾患或严重的慢性阻塞性气道疾患。2例在检查前局麻过程中死亡。4例经全身麻醉或注射吗啡后出现通气不足或低血压后发生心脏骤停而死亡。另3例在检查过程中突然死亡:1例检查时已处于临终状态,1例70岁患者有严重的阻塞性气道疾患,1例已94岁的患者在检查时突然死亡。从这些资料可以看出,术前给药或麻醉期间出现的心律失常是纤维支气管镜检查造成死亡的主要原因,老年人伴发严重阻塞性肺疾患或冠状动脉疾患对 Despite the safety of fibrobronchoscopy, careful analysis of its death and life-threatening complications is still necessary. Of the cases reported by Suratt, 2 died of massive bleeding due to endobronchial tumors during the examination and 11 had endobronchial lesions with life-threatening bleeding during biopsy or brushing. There are 10 patients died of cardiac arrest. Five of the deceased aged over 67 years. Most of these cases have coronary artery disease or severe chronic obstructive airways disease. Two patients died during the pre-test local anesthesia. Four patients died of cardiac arrest after general anesthesia or hypopnea or hypotension after injection of morphine. The other three died suddenly during the examination: one had been dead at the time of examination, one had severe obstructive airways disease at age 70, and one patient, 94, had died suddenly during the examination. From these data, it can be seen that the arrhythmia occurring during preoperative administration or anesthesia is the main cause of death due to fibrobronchoscopy, the elderly with severe obstructive pulmonary disease or coronary artery disease